Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 672 entries
View as:

Adherence, HIV-1 Infection, Resistance, and Renal and Skeletal Adverse Event in Individuals Taking Truvada® for HIV Pre-Exposure Prophylaxis (PrEP)

Phase: N/A Priority: Normal
NCT ID: NCT01906255 Org: User:
Start: 10/07/13 End: 04/27/21 Due: 04/27/22

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT04994509 Org: User:
Start: 08/30/21 End: 01/31/28 Due: 01/31/29

Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT01313624 Org: User:
Start: 04/30/11 End: 06/30/13 Due: 06/30/14

Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)

Phase: N/A Priority: Normal
NCT ID: NCT06104306 Org: User:
Start: 12/13/23 End: 04/23/25 Due: 04/23/26

A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01705847 Org: User:
Start: 11/30/12 End: 05/31/16 Due: 05/31/17

Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics

Phase: N/A Priority: Normal
NCT ID: NCT02654002 Org: User:
Start: 01/20/16 End: 07/14/16 Due: 07/14/17

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02932150 Org: User:
Start: 11/30/16 End: 10/31/29 Due: 10/31/30

Expanded Access for Idelalisib in Combination With Rituximab in Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02136511 Org: User:
Start: - End: - Due: -

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

Phase: N/A Priority: Normal
NCT ID: NCT04539262 Org: User:
Start: 09/14/20 End: 03/22/21 Due: 03/22/22

Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00596804 Org: User:
Start: 03/31/04 End: 11/30/07 Due: 11/30/08

PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00326157 Org: User:
Start: 06/30/06 End: 11/30/09 Due: 11/30/10

The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002327 Org: User:
Start: - End: - Due: -

Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT01106586 Org: User:
Start: 04/30/10 End: 09/30/14 Due: 09/30/15

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01721109 Org: User:
Start: 12/06/12 End: 01/29/18 Due: 01/29/19

Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women

Phase: N/A Priority: Normal
NCT ID: NCT02652624 Org: User:
Start: 02/19/16 End: 11/26/18 Due: 11/26/19

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

Phase: N/A Priority: Normal
NCT ID: NCT02881320 Org: User:
Start: 09/21/16 End: 09/30/25 Due: 09/30/26

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

Phase: N/A Priority: Normal
NCT ID: NCT02063997 Org: User:
Start: 03/31/14 End: 01/31/15 Due: 01/31/16

Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL

Phase: N/A Priority: Normal
NCT ID: NCT01728207 Org: User:
Start: 03/31/13 End: 03/31/17 Due: 03/31/18

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Phase: N/A Priority: Normal
NCT ID: NCT02413593 Org: User:
Start: 04/30/15 End: 01/31/16 Due: 01/31/17

Ranolazine in Diastolic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01163734 Org: User:
Start: 04/30/10 End: 02/28/11 Due: 02/28/12

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04292730 Org: User:
Start: 03/15/20 End: 06/26/20 Due: 06/26/21

A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL

Phase: N/A Priority: Normal
NCT ID: NCT01203930 Org: User:
Start: 10/31/10 End: 06/30/16 Due: 06/30/17

A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00117676 Org: User:
Start: 02/28/05 End: 01/31/16 Due: 01/31/17

Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01975675 Org: User:
Start: 10/31/13 End: 08/31/14 Due: 08/31/15

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02707601 Org: User:
Start: 04/01/16 End: 09/29/17 Due: 09/29/18